$7.7 B

NBIX Mkt cap, 18-Mar-2019

$451.2 M

Neurocrine Biosciences Revenue FY, 2018
Neurocrine Biosciences Gross profit (FY, 2018)446.4 M
Neurocrine Biosciences Gross profit margin (FY, 2018), %98.9%
Neurocrine Biosciences Net income (FY, 2018)21.1 M
Neurocrine Biosciences EBIT (FY, 2018)36.9 M
Neurocrine Biosciences Cash, 31-Dec-2018141.7 M

Neurocrine Biosciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.9m19.8m15.0m161.6m451.2m

Revenue growth, %

(100%)(24%)

Cost of goods sold

1.3m4.9m

Gross profit

160.4m446.4m

Gross profit Margin, %

99%99%

R&D expense

39.2m46.4m81.5m94.3m121.8m160.5m

General and administrative expense

13.3m18.0m32.5m68.1m169.9m248.9m

Operating expense total

52.6m64.4m114.0m162.4m293.0m414.3m

EBIT

(49.7m)(64.4m)(94.2m)(147.4m)(131.4m)36.9m

EBIT margin, %

(1702%)(477%)(982%)(81%)8%

Interest expense

19.5m30.5m

Pre tax profit

21.8m

Income tax expense

730.0k

Net Income

(46.1m)(60.5m)(88.9m)(141.1m)(142.5m)21.1m

Neurocrine Biosciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

44.8m31.0m74.2m83.3m254.7m141.7m

Accounts Receivable

31.1m56.2m

Inventories

10.9m

Current Assets

148.5m198.2m384.1m310.4m554.9m737.8m

PP&E

1.8m2.5m3.4m6.3m10.8m33.9m

Total Assets

154.7m243.0m474.8m365.1m817.6m993.2m

Accounts Payable

101.0k246.0k2.6m5.1m53.5m86.4m

Short-term debt

Current Liabilities

11.7m15.7m25.7m30.4m54.4m88.2m

Long-term debt

Total Debt

Total Liabilities

34.3m50.3m50.2m445.5m512.4m

Preferred Stock

Additional Paid-in Capital

886.1m1.0b1.3b1.4b1.6b1.7b

Retained Earnings

(765.8m)(826.3m)(915.2m)(1.1b)(1.2b)(1.2b)

Total Equity

120.4m208.7m424.5m314.9m372.1m480.8m

Financial Leverage

1.3 x1.2 x1.1 x1.2 x2.2 x2.1 x

Neurocrine Biosciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(46.1m)(60.5m)(88.9m)(141.1m)(142.5m)21.1m

Depreciation and Amortization

671.0k827.0k1.0m1.5m2.4m4.0m

Accounts Receivable

(31.1m)(25.1m)

Inventories

(1.0m)(3.5m)

Accounts Payable

(949.0k)9.8m4.4m27.3m24.2m

Cash From Operating Activities

(29.6m)(47.1m)(38.0m)(106.2m)(94.3m)101.4m

Purchases of PP&E

(545.0k)(1.6m)(1.9m)(4.1m)(6.9m)(24.8m)

Cash From Investing Activities

5.3m(105.4m)(195.8m)112.9m(250.9m)(242.9m)

Cash From Financing Activities

5.3m138.7m277.0m2.4m516.6m29.5m

Interest Paid

6.2m11.6m

Income Taxes Paid

Neurocrine Biosciences Ratios

USDY, 2018

Financial Leverage

2.1 x
Report incorrect company information

Neurocrine Biosciences Employee Rating

3.915 votes
Culture & Values
3.7
Work/Life Balance
3.8
Senior Management
3.6
Salary & Benefits
4.4
Career Opportunities
3.6
Source